EPA-Approved Products Expected to be Effective Against the Novel Coronavirus

Article Updated: June 15, 2021

As health and safety organizations continue to closely monitor the respiratory disease caused by the novel coronavirus (COVID-19), many have asked if Stepan has many U.S. EPA-approved registrations eligible for environmental infectious control of COVID-19 under the U.S. EPA's emerging viral pathogen guidance.

Stepan does offer 28 U.S. EPA-registered end use formulations that meet the criteria for applications against emerging viral pathogens, and therefore may be considered for use as hard surface disinfectants against SARS-CoV-2, the novel coronavirus that causes the disease COVID-19.

Subregistrants with a pre-qualified emerging viral pathogen claim can include a defined efficacy statement off-label in technical literature, non-label-related, websites, consumer information services, and social media sites, in accordance with the U.S. EPA's policy.

Along with a dedicated biocide team, we have a comprehensive portfolio of over 80 U.S. EPA-approved end use formulations that sanitize and disinfect in a wide variety of applications, including household and institutional cleaning, water treatment, oilfield and wood preservation. Please let us know how we can support you. If you would like to learn more or have any questions, please call 1-800-745-7837 or contact the Stepan Company North America Technical Service Department at techserv@stepan.com.